The Glutamate Hypothesis of Schizophrenia: Advances, Limitations, and Future Directions in Treating Chronic Psychosis

Grand Rounds

Event Info

Breadcrumb

  1. Events
  2. Grand Rounds
  3. The Glutamate Hypothesis of Schizophrenia: Advances, Li...

The Glutamate Hypothesis of Schizophrenia: Advances, Limitations, and Future Directions in Treating Chronic Psychosis


27February

Event Info
Category Date and Time
  • Wednesday, February 27, 2019
  • 01:00 PM - 02:00 PM
Topic and Speaker
  • The Glutamate Hypothesis of Schizophrenia: Advances, Limitations, and Future Directions in Treating Chronic Psychosis
  • Jenifer R. Lloyd MD
    • Assistant Professor of Clinical Psychiatry
    • UIH Clerkship Site Director
    • University of Illinois at Chicago
    Jenifer R. Lloyd

Location
  • School of Public Health / Psychiatric Institute (SPHPI)
  • 1601 W. Taylor St.
  • Chicago IL 60612
Conference Room
  • 109 (Auditorium)
Video Recording
Event Details

Dr. Lloyd is in her eighth year at UIC, where she completed medical school and is finishing up her Adult Psychiatry Residency. This year she has enjoyed adding breadth to her psychiatric knowledge through her elective Recovery and Mood and Anxiety Clinics, but her primary interests lie in treating severe mental illness and its frequent companion, catatonia, in underserved populations. She intends to stay on at UIC after graduation as a faculty member, where preliminary plans have her dividing her time between serving as an attending on the inpatient unit, delivering ECT, supervising resident-run clinics, and caring for some of her own outpatient medication management and psychotherapy patients.


Audience:

Psychiatrists, Neurologists, and other affiliated professionals interested in mental health

Purpose:

To provide current information on research, treatment, and policy issues relating to psychiatry and its adjunct fields

Instructional level:

Advanced

Objectives:

  1. Describe why and how the dopamine hypothesis does not adequately describe the pathophysiology of schizophrenia
  2. Describe and discuss the glutamate hypothesis of schizophrenia
  3. Identify some alternative, glutamate-based pharmacologic agents for which there is evidence to support their use in treating refractory symptoms in schizophrenia

The University of Illinois at Chicago (UIC) College of Medicine is accredited by the Accreditation Council for Continuing Medical Education ACCME) to provide continuing medical education for physicians.

The University of Illinois at Chicago (UIC) College of Medicine designates this live activity for a maximum of 1credit AMA PRA Category 1 credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Continuing Education Units (1) will be available for Social Workers and affiliated reciprocal agencies. Illinois Board License number 159-000112.

The Department of Psychiatry at the University of Illinois at Chicago is approved by the American Psychological Association to sponsor continuing education for psychologists.  The Department of Psychiatry at the University of Illinois at Chicago maintains responsibility for this program and its content. This event is 1 credit hour continuing education.

No member of the planning committee for this activity have reported a relevant relationship with a commercial interest.  There is no conflict of interest and nothing to disclose.

Dr. Lloyd has no relevant financial relationship with commercial interests related to this CME activity.

Map